We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Green Tea Compound Lowers Risk Of Type 1 Diabetes Onset In Mice

December 9, 2010: 08:58 PM EST

U.S. researchers working with mice have found that epigallocatechin gallate (EGCG), a compound found in green tea, reduced the risk of developing type 1 diabetes by about 40 percent, probably due to the compound’s anti-inflammatory activity. In the study, which used mice that spontaneously develop type-1 diabetes, one group was fed a control diet, while a second group was given a supplemental dose of EGCG in drinking water. At 32 weeks more than two-thirds of the animals in the control group had developed diabetes, while only a fourth of the EGCG group developed diabetes. The researchers suggested that EGCG probably “exerts a cytoprotective effect on human pancreatic islets exposed to the inflammatory milieu relevant to type 1 diabetes” but said further studies are needed to determine the exact mechanism before clinical trials are launched.

Zhuo Fu, et al., "Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice", British Journal of Nutrition, December 09, 2010, © The authors
Domains
TrendSpotter
Vitality & Better Living
Geographies
Worldwide
North America
EMEA
United States of America
Europe
United Kingdom
Categories
Research, Studies, Advice
Developed by Yuri Ingultsov Software Lab.